Pekin Hardy Strauss, Inc. - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Pekin Hardy Strauss, Inc. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$220,000
+39.2%
22,000
+4.8%
0.02%
+58.3%
Q2 2014$158,00021,0000.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders